Literature DB >> 27749444

A Comparison of Mohs Micrographic Surgery and Wide Local Excision for Treatment of Dermatofibrosarcoma Protuberans With Long-Term Follow-up: The Mayo Clinic Experience.

Garrett C Lowe1, Oluwakemi Onajin, Christian L Baum, Clark C Otley, Christopher J Arpey, Randall K Roenigk, Jerry D Brewer.   

Abstract

BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is a soft tissue tumor with slow infiltrative growth and local recurrence if inadequately excised.
OBJECTIVE: To compare long-term outcomes after Mohs micrographic surgery (MMS) and wide local excision (WLE).
MATERIALS AND METHODS: Records of patients with DFSP surgically treated with WLE or MMS from January 1955 through March 2012 were retrospectively reviewed.
RESULTS: Mean follow-up for patients treated with MMS (n = 67) and WLE (n = 91) was 4.8 and 5.7 years, respectively. Twenty-eight patients (30.8%) with WLE had recurrence (mean, 4.4 years), whereas only 2 (3.0%) with MMS had recurrence (1.0 and 2.6 years). Recurrence-free survival rates at 1, 5, 10, and 15 years were significantly higher with MMS (p < .001). Mean preoperative lesion sizes were similar (5-6 cm) between the 2 groups, whereas mean (standard deviation) postoperative defect sizes were 10.7 (4.3) cm and 8.8 (5.5) cm for WLE and MMS, respectively (p = .004). Primary closure was used for 73% of MMS cases, whereas WLE more commonly used flaps, grafts, or other closures (52%). Two Mohs layers typically were required for margin control.
CONCLUSION: Surgical excision with meticulous histologic evaluation of all surgical margins is needed for DFSP treatment to achieve long-term high cure rates and low morbidity.

Entities:  

Mesh:

Year:  2017        PMID: 27749444     DOI: 10.1097/DSS.0000000000000910

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  16 in total

Review 1.  Mohs Micrographic Surgery: Development, Technique, and Applications in Cutaneous Malignancies.

Authors:  Eillen Luisa A Chen; Divya Srivastava; Rajiv I Nijhawan
Journal:  Semin Plast Surg       Date:  2018-05-14       Impact factor: 2.314

2.  Patient indications for Mohs micrographic surgery: a clinical practice guideline.

Authors:  C Murray; D Sivajohanathan; T P Hanna; S Bradshaw; N Solish; B Moran; R Hekkenberg; A C Wei; T Petrella
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

Review 3.  Dermatofibrosarcoma Protuberans.

Authors:  Alvaro E Acosta; Catalina Santa Vélez
Journal:  Curr Treat Options Oncol       Date:  2017-08-10

4.  Micrographic Surgery Allows Fascia Preservation in Dermatofibro-sarcoma Protuberans.

Authors:  Maximilian Gassenmaier; Erik Weber; Ulrike Leiter; Matthias Hahn; Stephan Forchhammer; Hans-Martin Häfner; Alexander Scheu; Claus Garbe; Saskia Schnabl
Journal:  Acta Derm Venereol       Date:  2021-09-28       Impact factor: 3.875

Review 5.  Dermatofibrosarcoma Protuberans in Children.

Authors:  Aseel Sleiwah; Thomas C Wright; Thomas Chapman; Adam Dangoor; Francesca Maggiani; Rachel Clancy
Journal:  Curr Treat Options Oncol       Date:  2022-04-08

6.  Dermoscopy of Dermatofibrosarcoma Protuberans: What Do We Know?

Authors:  Gabriela F Escobar; Caroline K Ribeiro; Leandro L Leite; Carolina R Barone; André Cartell
Journal:  Dermatol Pract Concept       Date:  2019-04-30

7.  Collagen Features of Dermatofibrosarcoma Protuberans Skin Base on Multiphoton Microscopy.

Authors:  Shulian Wu; Yudian Huang; Zhifang Li; Huaqing Wu; Hui Li
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

8.  Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review.

Authors:  Cristian Navarrete-Dechent; Shoko Mori; Christopher A Barker; Mark A Dickson; Kishwer S Nehal
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

Review 9.  Cutaneous soft tissue sarcomas: survival-related factors.

Authors:  Areti Gkantaifi; Alexandros Diamantis; Davide Mauri; Ioanna Nixon; Anastassios Kyriazoglou; Ioannis Baloyiannis; Nikolaos Tsoukalas; Nikolaos Charalampakis; Dimitrios Schizas; Francesco Cuccia; Filippo Alongi; Ramon Andrade de Mello; George Iliadis; Konstantinos Kamposioras; Michalis Mazonakis; Maria Tolia
Journal:  Arch Dermatol Res       Date:  2021-07-17       Impact factor: 3.033

10.  Recurrent dermatofibrosarcoma protuberans treated with neoadjuvant imatinib mesylate followed by Mohs micrographic surgery.

Authors:  Natalia M Fontecilla; Nicole W Kittler; Larisa Geskin; Faramarz H Samie; George Niedt; Thomas Imahiyerobo; Gary Schwartz; Matt Ingham; Jesse M Lewin
Journal:  JAAD Case Rep       Date:  2017-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.